Synergistic Interaction of Methanol Extract from Canarium odontophyllum Miq. Leaf in Combination with Oxacillin against Methicillin-Resistant Staphylococcus aureus (MRSA) ATCC 33591.

Dayang Fredalina Basri, Vimashiinee Sandra
Author Information
  1. Dayang Fredalina Basri: School of Diagnostic & Applied Health Sciences, Faculty of Health Sciences, Universiti Kebangsaan Malaysia, Jalan Raja Muda Abdul Aziz, 50300 Kuala Lumpur, Malaysia. ORCID
  2. Vimashiinee Sandra: School of Diagnostic & Applied Health Sciences, Faculty of Health Sciences, Universiti Kebangsaan Malaysia, Jalan Raja Muda Abdul Aziz, 50300 Kuala Lumpur, Malaysia.

Abstract

Canarium odontophyllum (CO) Miq. has been considered as one of the most sought-after plant species in Sarawak, Malaysia, due to its nutritional and pharmacological benefits. This study aimed to evaluate the pharmacodynamic interaction of crude methanol and acetone extracts from CO leaves in combination with oxacillin, vancomycin, and linezolid, respectively, against MRSA ATCC 33591 as preliminary study has reported its potential antistaphylococcal activity. The broth microdilution assay revealed that both methanol and acetone extracts were bactericidal with Minimum Inhibitory Concentration (MIC) of 312.5 μg/mL and 156.25 μg/mL and Minimum Bactericidal Concentration (MBC) of 625 μg/mL and 312.5 μg/mL, respectively. Fractional Inhibitory Concentration (FIC) indices were obtained via the chequerboard dilution assay where methanol extract-oxacillin, acetone extract-oxacillin, methanol extract-linezolid, and acetone extract-linezolid combinations exhibited synergism (FIC index ≤ 0.5). The synergistic action of the methanol extract-oxacillin combination was verified by time-kill analysis where bactericidal effect was observed at concentration of 1/8 × MIC of both compounds at 9.6 h compared to oxacillin alone. As such, these findings postulated that both extracts exert their anti-MRSA mechanism of action similar to that of vancomycin and provide evidence that the leaves of C. odontophyllum have the potential to be developed into antistaphylococcal agents.

References

  1. J Chiropr Med. 2012 Mar;11(1):64-76 [PMID: 22942844]
  2. Evid Based Complement Alternat Med. 2012;2012:838604 [PMID: 22811751]
  3. F1000 Med Rep. 2012;4:4 [PMID: 22312414]
  4. Antimicrob Agents Chemother. 2006 Nov;50(11):3622-30 [PMID: 16954318]
  5. J Clin Pathol. 1962 Jul;15:328-38 [PMID: 13897086]
  6. Nat Prod Rep. 2004 Apr;21(2):263-77 [PMID: 15042149]
  7. J Nat Med. 2010 Apr;64(2):212-5 [PMID: 20119720]
  8. J Infect Dis. 2011 Aug 1;204(3):329-31 [PMID: 21742827]
  9. Evid Based Complement Alternat Med. 2012;2012:493156 [PMID: 22899953]
  10. Antimicrob Agents Chemother. 1993 Mar;37(3):613-5 [PMID: 8460929]
  11. Biomed Res Int. 2014;2014:461756 [PMID: 24783205]
  12. Clin Infect Dis. 2004 Mar 15;38(6):864-70 [PMID: 14999632]
  13. Curr Drug Targets. 2011 Jan;12(1):122-32 [PMID: 20735354]
  14. J Antimicrob Chemother. 2003 Apr;51(4):857-64 [PMID: 12654769]
  15. J Antimicrob Chemother. 2003 Jul;52(1):1 [PMID: 12805255]
  16. J Biomed Sci. 2014 Sep 11;21:90 [PMID: 25208614]
  17. Int J Antimicrob Agents. 2000 Jul;15(2):125-9 [PMID: 10854808]
  18. Curr Clin Top Infect Dis. 1987;8:204-26 [PMID: 3151759]
  19. PLoS One. 2012;7(8):e43213 [PMID: 22927951]
  20. Clin Microbiol Infect. 2005 Jun;11(6):510-2 [PMID: 15882206]
  21. Clin Infect Dis. 2007 May 1;44(9):1208-15 [PMID: 17407040]
  22. Indian J Med Res. 2011 Nov;134(5):704-8 [PMID: 22199111]
  23. Lancet. 2001 Jul 21;358(9277):207-8 [PMID: 11476839]
  24. Ann Clin Microbiol Antimicrob. 2011 Jun 09;10:25 [PMID: 21658242]
  25. J Clin Microbiol. 2006 Nov;44(11):3883-6 [PMID: 16957043]
  26. Phytomedicine. 2009 Mar;16(2-3):97-110 [PMID: 19211237]
  27. Phytomedicine. 2008 Aug;15(8):639-52 [PMID: 18599280]
  28. Indian J Med Res. 2005 Jul;122(1):80-4 [PMID: 16106094]

Word Cloud

Created with Highcharts 10.0.0methanolacetoneodontophyllumextractsConcentrationextract-oxacillinCanariumCOMiqstudyleavescombinationoxacillinvancomycinrespectivelyMRSAATCC33591potentialantistaphylococcalassaybactericidalMinimumInhibitoryMIC3125 μg/mLFICextract-linezolidactionconsideredonesought-afterplantspeciesSarawakMalaysiaduenutritionalpharmacologicalbenefitsaimedevaluatepharmacodynamicinteractioncrudelinezolidpreliminaryreportedactivitybrothmicrodilutionrevealed15625 μg/mLBactericidalMBC625 μg/mLFractionalindicesobtainedviachequerboarddilutioncombinationsexhibitedsynergismindex05synergisticverifiedtime-killanalysiseffectobservedconcentration1/8×compounds96 hcomparedalonefindingspostulatedexertanti-MRSAmechanismsimilarprovideevidenceCdevelopedagentsSynergisticInteractionMethanolExtractLeafCombinationOxacillinMethicillin-ResistantStaphylococcusaureus

Similar Articles

Cited By